Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHemogenyx Pharmaceuticals Regulatory News (HEMO)

Share Price Information for Hemogenyx Pharmaceuticals (HEMO)

Share Price is delayed by 15 minutes
Get Live Data
719.00    -5.00 (-0.69%)
Bid:
719.00
Ask:
745.00
Spread: 26.00 (3.616%)
Market Cap: £48.89m
HEMO Live PriceLast checked at - London Stock Exchange

Intraday Hemogenyx Pharmaceuticals Share Chart

Statement re possible acquisition

30 Dec 2015 07:00

RNS Number : 3726K
Silver Falcon PLC
30 December 2015
 

30 December 2015

SILVER FALCON PLC

("Silver Falcon" or the "Company")

 

Proposed acquisition of Lime Holdings Limited ("Lime")

 

Silver Falcon plc (LSE:SILF), the listed special purpose acquisition company, refers to its announcement of 23 December 2015 and is pleased to advise that it has entered into a non-binding Memorandum of Understanding with the board and principal shareholder in Lime Holdings Limited ("Lime") regarding a possible acquisition of 100% of the share capital of Lime by way of a share for share exchange ("Transaction").

Lime is an Australian unlisted public company which operates in the financial technology sector. It has developed an innovative platform for the insurance industry which facilitates the automated delivery of insurance to end users.

Lime has recently relocated its headquarters to the UK and is developing commercial partnerships in the UK and on an international basis.

Whilst a general understanding on the terms of the Transaction has been reached, these terms are subject to due diligence, a fundraising, and re-listing of the enlarged group on the London Stock Exchange. Accordingly there is no certainty that it will be completed.

If the Transaction is completed, it will constitute a reverse takeover under the Listing Rules. As the Company is unable to provide full disclosure under Rule 5.6.15 of the Listing Rules, the Company has requested a continuation of the current suspension of trading in its shares.

Further announcements will be made in due course as the Transaction progresses.

 

For further information please contact:

Silver Falcon: Tim Le Druillenec (Company Secretary), 07874 762821

Media enquiries: Jennifer Renwick, jennifer.renwick@camarco.co.uk, 0203 757 4994

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
ACQTLBPTMBTTBAA
Date   Source Headline
18th Nov 20204:41 pmRNSSecond Price Monitoring Extn
18th Nov 20204:36 pmRNSPrice Monitoring Extension
18th Nov 20202:06 pmRNSSecond Price Monitoring Extn
18th Nov 20202:01 pmRNSPrice Monitoring Extension
18th Nov 202010:39 amRNSFinancing Facility of up to £60 Million
27th Oct 20207:00 amRNSCDX Development Agreement Further Extension
19th Oct 20207:00 amRNSPresentation at the American Society of Hematology
6th Oct 20207:00 amRNSSAFE-HEMO-CAR-T Effective against AML in vitro
30th Sep 20207:00 amRNSInterim Results for the period ended 30 June 2020
22nd Sep 202012:52 pmRNSFurther re. Grant of Options
10th Sep 20204:40 pmRNSSecond Price Monitoring Extn
10th Sep 20204:35 pmRNSPrice Monitoring Extension
26th Aug 20202:06 pmRNSSecond Price Monitoring Extn
26th Aug 20202:00 pmRNSPrice Monitoring Extension
25th Aug 20204:40 pmRNSSecond Price Monitoring Extn
25th Aug 20204:35 pmRNSPrice Monitoring Extension
21st Aug 20209:52 amRNSGrant of Options
14th Aug 20207:00 amRNSPresentations at Cancer Immunotherapy Symposia
11th Aug 20207:00 amRNSCAR-T Agreement with University of Pennsylvania
31st Jul 20207:00 amRNSBroker's Research Note
20th Jul 20204:40 pmRNSSecond Price Monitoring Extn
20th Jul 20204:35 pmRNSPrice Monitoring Extension
20th Jul 20202:05 pmRNSSecond Price Monitoring Extn
20th Jul 20202:00 pmRNSPrice Monitoring Extension
14th Jul 202011:00 amRNSPrice Monitoring Extension
14th Jul 20209:06 amRNSSecond Price Monitoring Extn
14th Jul 20209:00 amRNSPrice Monitoring Extension
13th Jul 20204:36 pmRNSPrice Monitoring Extension
13th Jul 20203:16 pmRNSGrant of Options
13th Jul 20203:13 pmRNSFurther re Development Agreement
10th Jul 20201:00 pmRNSUS Subsidiary Change of Name
6th Jul 20207:00 amRNSNew Corporate Video and Investor Webinar
1st Jul 202012:58 pmRNSTotal Voting Rights
30th Jun 20204:40 pmRNSSecond Price Monitoring Extn
30th Jun 20204:35 pmRNSPrice Monitoring Extension
30th Jun 20202:06 pmRNSSecond Price Monitoring Extn
30th Jun 20202:00 pmRNSPrice Monitoring Extension
30th Jun 202010:30 amRNSDirector/PDMR Shareholding
26th Jun 20202:06 pmRNSSecond Price Monitoring Extn
26th Jun 20202:00 pmRNSPrice Monitoring Extension
26th Jun 202011:05 amRNSSecond Price Monitoring Extn
26th Jun 202011:00 amRNSPrice Monitoring Extension
26th Jun 20209:05 amRNSSecond Price Monitoring Extn
26th Jun 20209:00 amRNSPrice Monitoring Extension
26th Jun 20207:00 amRNSDevelopment Agmnt - Autoimmune Disease Treatments
24th Jun 20207:00 amRNSHemogenyx Chairman Receives Tang Prize
19th Jun 20202:06 pmRNSSecond Price Monitoring Extn
19th Jun 20202:01 pmRNSPrice Monitoring Extension
15th Jun 20207:00 amRNSCOVID-19 Project Update
9th Jun 202011:05 amRNSSecond Price Monitoring Extn

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.